Crescita Therapeutics Inc. Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Crescita's board of directors and management team have demonstrated success in building Crescita's predecessor company, Nuvo Research Inc., including developing multiple drugs that are now approved and commercialized and negotiating multiple licensing transactions. For additional information, please visit www.crescitatherapeutics.com.

Contact Information:
Investor Relations, Email: [email protected]

Latest

May 27, 2020, 07:30 ET Crescita Reports First Quarter 2020 Results

Positive Adjusted EBITDA1 and Cash Flow LAVAL, QC, May 27, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita" or "the Company"), a growth-oriented,...


May 14, 2020, 08:30 ET Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders

LAVAL, QC, May 14, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company with...


Apr 28, 2020, 17:58 ET Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19

LAVAL, QC, April 28, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") today announced that pursuant to the exemption provided in Ontario Instrument...


Mar 24, 2020, 19:23 ET Crescita Therapeutics Announces Measures in Response to COVID-19 Virus

LAVAL, QC, March 24, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company...


Mar 18, 2020, 07:30 ET Crescita Reports Q4 and Fiscal 2019 Results

Record Annual Revenue of $22.3M Record Adjusted EBITDA of $7.0M up from $1.5M LAVAL, QC, March 18, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX OTC) (US: CRRTF) ("Crescita" or the "Company"), a...


Mar 10, 2020, 09:30 ET Pliaglis® finally available in Canada

MONTREAL, March 10, 2020 /CNW Telbec/ - The topical analgesic Pliaglis has long been awaited by many doctors and dermatologists in Canada because it offers patients an effective alternative to...


Feb 11, 2020, 07:30 ET Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis

Primary Endpoint Achieved with High Statistical Significance LAVAL, QC, Feb. 11, 2020 /CNW/ – Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial...


Jan 24, 2020, 07:30 ET Crescita Awarded Cannabis Research License from Health Canada

LAVAL, QC, Jan. 24, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial dermatology company with manufacturing capabilities and a...


Jan 22, 2020, 07:30 ET Crescita Secures Line of Credit with the Royal Bank of Canada Following Repayment in Full of Knight Therapeutics Loan

Laval, QC, Jan. 22, 2020 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a commercial dermatology company with manufacturing capabilities and a portfolio...


Jan 20, 2020, 07:30 ET Crescita Signs Exclusive Distribution Agreement with FILLMED

Crescita to Distribute NCTF® and ART FILLER® Injectables in Canada LAVAL, QC, Jan. 20, 2020 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) ("Crescita" or the "Company"), a...


Nov 07, 2019, 07:30 ET Crescita Reports 2019 Third Quarter Results

Revenue up 9.9% Year-over-Year Positive Adjusted EBITDA1 of $0.9 Million LAVAL, QC, Nov. 7, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian...


Nov 05, 2019, 18:26 ET U.S. Food and Drug Administration Approves Enhanced Formulation of Pliaglis®

LAVAL, QC, Nov. 5, 2019 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita"), a commercial dermatology company with manufacturing capabilities and a portfolio of...


Oct 28, 2019, 07:30 ET Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals

CALGARY and LAVAL, QC, Oct. 28, 2019 /CNW/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed producer of cannabis and Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF)...


Sep 05, 2019, 07:00 ET Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

LAVAL, QC, Sept. 5, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a...


Aug 08, 2019, 07:30 ET Crescita Reports Profitable 2019 Second Quarter Results

Record Revenue of $9.4 Million and Adjusted EBITDA of $5.1 Million LAVAL, QC, Aug. 8, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian...


Jul 16, 2019, 07:30 ET United States Patent and Trademark Office Issues U.S. Patent Covering an Enhanced Formulation of Pliaglis®

LAVAL, QC, July 16, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare...


Jul 11, 2019, 07:30 ET Crescita Therapeutics to Host Investor Webcast on July 24, 2019

LAVAL, QC, July 11, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare...


Jul 04, 2019, 07:30 ET Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of Pliaglis by Cantabria in Italy

LAVAL, QC, July 4, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare...


Jun 26, 2019, 07:00 ET Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

LAVAL, QC, June 26, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") announced today that the Toronto Stock Exchange (the "TSX") has approved the...


Jun 17, 2019, 20:17 ET Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer Bid

LAVAL, QC, June 17, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a Canadian commercial dermatology company with a portfolio of non-prescription...


May 30, 2019, 08:00 ET Crescita to Present at the 9th Annual LD Micro Invitational in Los Angeles, California

LAVAL, QC, May 30, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription...


May 29, 2019, 08:00 ET Crescita Therapeutics Engages Bristol Capital to Provide Investor Relations and Communications Services

LAVAL, QC, May 29, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription...


May 15, 2019, 08:30 ET Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

LAVAL, QC, May 15, 2019 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare...


May 15, 2019, 07:30 ET Crescita Therapeutics Reports 2019 First Quarter Results

Year-over-Year Revenue Growth of 16.4% Positive Adjusted EBITDA for Third Consecutive Quarter And Generates $2.3 Million in Cash LAVAL, QC, May 15, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX)...


May 07, 2019, 08:00 ET Crescita Therapeutics Strengthens Leadership Team with New Vice-President in Aesthetic and Cosmeceutical Business Unit

LAVAL, QC, May 7, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare ...